DADATA·ANALYSIS
FREE
company · cik 1808805

Nautilus Biotechnology, Inc.

NAUTNasdaqSIC 3826public
financials · annual · usd2026
Net income-$59.0M
Total assets$191.1M
Total liabilities$34.1M
Equity$157.0M
Operating cash-$50.7M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts1